✦ LIBER ✦

Identification of Metadherin as a Novel Target of miR-375 in Head and Neck Cancer

✍ Scribed by F. Liu

Book ID: 118455885
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 38 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

R422 – EMMPRIN as a Novel Target in Head

R422 – EMMPRIN as a Novel Target in Head and Neck Cancer

✍ Seena Safavy; Nichole Dean; John Robert Newman; Wenyue Zhang; David Michael Week 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 35 KB

SP236 – miR-210 as a novel hypoxia marke

SP236 – miR-210 as a novel hypoxia marker in head and neck cancer

✍ Allen S. Ho; Xin Huang; Hongbin Cao; Quyhn-Thu Le 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 72 KB

487 IDENTIFICATION OF PURINE NUCLEOSIDE

487 IDENTIFICATION OF PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) AS A NOVEL TARGET OF TUMOR SUPPRESSORS MIR-1 AND MIR-133A IN PROSTATE CANCER

✍ Kojima, Satoko; Chiyomaru, Takeshi; Yoshino, Hirofumi; Enokida, Hideki; Nohata, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 159 KB

Molecular-cytogenetic characterization o

Molecular-cytogenetic characterization of head and neck cancer: Identification of novel prognostic factors and gene targets for therapy

✍ Robert L. Ferris 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Mitochondria as a critical target of the

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

✍ Kevin J. Cullen; Zejia Yang; Lisa Schumaker; Zhongmin Guo 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

Cyclooxygenase-2: A novel molecular targ

Cyclooxygenase-2: A novel molecular target for the prevention and treatment of head and neck cancer

✍ Derrick T. Lin; Kotha Subbaramaiah; Jatin P. Shah; Andrew J. Dannenberg; Jay O. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Cyclooxygenase‐2 (COX‐2), an enzyme that catalyzes the synthesis of prostaglandins, is overexpressed in a variety of premalignant and malignant conditions, including oral leukoplakia and squamous cell carcinoma of the head and neck. Increased levels of COX‐2 may contribute to carcinogen